4. Abingworth 1973
7. Advaxis 2002
9. Aeris Capital 2006
18. Amgen Ventures 2004
19. aMoon Fund 0
20. Anaxago 1
21. Andera Partners 1953
22. Apax Partners 1981
27. ArmaVir Partners 2018
32. AT Impf
46. Bio Jag 2006
49. BioNTech
52. BlackRock 0
53. Blackstone Group 1985
58. Bpifrance 0
66. BVF Partners 1993
67. BXR Partners LLP 2010
69. Calculus Capital 1999
74. Cancer Rop 2001
77. Care Capital 2000
79. Celgene 0
80. CG Oncology 2010
81. Chartwave
91. CRG
94. DAG Ventures 2004
96. DARPA 0
97. DBJ Capital 2010
98. Deerfield 1994
101. Domain Associates 1985
102. Droia Ventures 2011
106. EDBI
107. EFung Capital 1996
109. EIR Ventures 2020
110. EMBL Ventures 2001
112. Eurazeo 0
116. Evotec 1993
122. Flerie Invest 2011
128. Fund+
131. GeneMatrix 2000
132. Genentech 1976
135. Genzyme 1981
136. GeoVax 1988
141. Global Bio Fund 2020
153. Horizon Capital 2006
155. Hygea VCT 2001
156. IBIS Capital 2003
158. Index Ventures 1996
160. Innovation Engine 2001
164. Invus 1985
167. IP Group 2001
171. JDRF T1D Fund 2016
173. Jefferies 1962
175. K2 HealthVentures 2018
177. KfW 1948
180. Kite Pharma 2009
184. Korify Capital AG 2020
185. Kreftforeningen 1938
186. KSP 1986
187. Kukje Pharma 1958
192. Leerink Partners 1995
203. LSP
204. LSP BioVentures 2006
211. MBLVC 2000
212. Merck 1900
214. Merlin Nexus 2001
226. MRL Ventures Fund 2014
227. NantWorks 2010
231. Natixis 1919
233. NewLink Genetics 1999
234. NexImmune 2011
235. NextWaveBio 2018
242. Novateur Ventures 2015
245. Oncorus 2015
246. OrbiMed
259. Piedmont Capital 2005
261. PMV
262. Point72 2012
263. PPF Group 1991
266. PSP Investments 1999
270. Quan Capital 2017
271. Quantum 1980
272. Quark Venture 2015
276. Regeneron 1988
277. Replimune Group 2015
278. Ridgeback Capital 2006
280. Roche
284. RUSNANO 2007
285. S.R.I.W. 1979
286. Sambrinvest 1985
292. Sante Ventures 2006
293. Schroder Adveq 1997
296. SFPI-FPIM
301. Sirnaomics 2007
302. Sirona Capital 2009
310. Square 1 Bank 2005
311. SR One
314. Surveyor Capital 2008
317. T. Rowe Price 0
318. Takeda 1781
322. Tencent 0
323. Teralys Capital 2009
324. Tera Science 1993
326. Tethys BioScience 2002
332. TVM Capital 1983
333. Two River 2004
336. UTC Investment Co. 1988
348. Xfund 2012
349. Yijing Capital 2015
352. Ysios Capital 2008

«Cancer Vaccine Industry Q3 2022- by Antigen Type»

  • — organisation
  • — investor and funding support bodies
  • — hubs and other organisation types

test_custom_domain_2
© 2026